Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus
- PMID: 17112740
- DOI: 10.1016/j.neuroimage.2006.09.029
Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus
Abstract
Cerebral atrophy has been described to occur in systemic lupus erythematosus (SLE) with variable frequency. The aim of this study was to determine white and gray matter abnormalities in brain magnetic resonance imaging (MRI) of patients with SLE and to determine if these abnormalities progress over a one-year period. Seventy-five patients with SLE and 44 healthy age and sex-matched controls were enrolled in this study. T1-weighted volumetric images were used for voxel based morphometry (VBM) analyses. SLE patients exhibited a significant reduction in white matter and gray matter volume compared to controls (p=0.001). Follow-up images, after an average interval of 19 months, revealed a progressive white matter and gray matter atrophy (p=0.001). Reduced white and gray matter volume was associated with disease duration and the presence of antiphospholipid antibodies. Patients with severe cognitive impairment had a more pronounced white and gray matter reduction than patients with moderate cognitive impairment. Total corticosteroid dose was associated with gray matter reduction and not with white matter loss in SLE patients. We concluded that brain tissue loss associated with SLE is significant and progresses over a relatively short period of time. Disease duration, the presence of antiphospholipid antibodies and cognitive impairment were associated with white and gray matter loss. Corticosteroid was associated only with gray matter atrophy.
Similar articles
-
Cerebral and corpus callosum atrophy in systemic lupus erythematosus.Arthritis Rheum. 2005 Sep;52(9):2783-9. doi: 10.1002/art.21271. Arthritis Rheum. 2005. PMID: 16142703
-
Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study.Scand J Rheumatol. 2005 Sep-Oct;34(5):376-82. doi: 10.1080/03009740510026643. Scand J Rheumatol. 2005. PMID: 16234185
-
Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.Mult Scler. 2009 Feb;15(2):204-11. doi: 10.1177/1352458508098270. Epub 2008 Nov 5. Mult Scler. 2009. PMID: 18987104
-
Overwhelming leukoencephalopathy as the only sign of neuropsychiatric lupus.J Rheumatol. 2005 Sep;32(9):1843-5. J Rheumatol. 2005. PMID: 16142887 Review.
-
[Psychiatric disorders in rheumatic diseases, as exemplified by systemic lupus erythematosus (SLE)].Z Rheumatol. 2004 Apr;63(2):122-30. doi: 10.1007/s00393-004-0618-z. Z Rheumatol. 2004. PMID: 15112090 Review. German.
Cited by
-
Anti-NR2A/B Antibodies and Other Major Molecular Mechanisms in the Pathogenesis of Cognitive Dysfunction in Systemic Lupus Erythematosus.Int J Mol Sci. 2015 May 6;16(5):10281-300. doi: 10.3390/ijms160510281. Int J Mol Sci. 2015. PMID: 25955648 Free PMC article. Review.
-
Cortical thickness and subcortical gray matter reductions in neuropsychiatric systemic lupus erythematosus.PLoS One. 2010 Mar 24;5(3):e9302. doi: 10.1371/journal.pone.0009302. PLoS One. 2010. PMID: 20352085 Free PMC article.
-
White matter hyperintensities associate with cognitive slowing in patients with systemic lupus erythematosus and neuropsychiatric symptoms.RMD Open. 2021 Jul;7(2):e001650. doi: 10.1136/rmdopen-2021-001650. RMD Open. 2021. PMID: 34321253 Free PMC article.
-
Prevalence of neuropsychiatric disorders in patients with systemic lupus erythematosus in Pakistan: A systematic review and meta-analysis.Front Psychiatry. 2023 Feb 2;14:1098734. doi: 10.3389/fpsyt.2023.1098734. eCollection 2023. Front Psychiatry. 2023. PMID: 36816415 Free PMC article.
-
Neuropsychiatric manifestations in systemic lupus erythematosus: epidemiology, pathophysiology and management.CNS Drugs. 2011 Sep 1;25(9):721-36. doi: 10.2165/11591670-000000000-00000. CNS Drugs. 2011. PMID: 21870886 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources